MedPath

Patient Registry: Radio Frequency Ablation of Barrett's Esophagus Using HALO System

Conditions
Barrett's Esophagus
Registration Number
NCT02033070
Lead Sponsor
Ochsner Health System
Brief Summary

The purpose of this study is to provide a tool for physicians to compare outcome data related to the use of the HALO Ablation Systems. This study is a single-center patient registry which will contribute to a framework for treatment and follow-up of patients with Barrett's Esophagus.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • candidate for ablation of Barrett's Esophagus with the HALO Ablation System (Prospective)
  • received an ablation with the HALO Ablation System to treat Barrett's Esophagus (Retrospective)
  • candidate agrees to proposed follow-up schedule of yearly surveillance following treatment
  • signs consent
Exclusion Criteria
  • has not been diagnosed with Barrett's Esophagus

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Endoscopic clearance rate for Barrett's EsophagusOutcome measure is assessed at Month 12
Secondary Outcome Measures
NameTimeMethod
Histological clearance rate for intestinal metaplasiaBiopsy taken at 12 months

Trial Locations

Locations (1)

Ochsner Medical Center

🇺🇸

Kenner, Louisiana, United States

© Copyright 2025. All Rights Reserved by MedPath